Mosapride citrate

Phase 2Small molecule

IlDong Pharmaceutical Co Ltd

Mosapride citrate is one of 6 small molecule programs targeting Gastrointestinal. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

GastrointestinalCompleted

Gastrointestinal DysfunctionRecruiting

GastrointestinalPreclinical

Completed

Gastrointestinal DysfunctionPhase 2

Recruiting

Competition

Competitive Landscape

18 competitors in Gastrointestinal

#DrugCompanyPhaseTrials

Movantik

AAveritas Pharma, Inc.

Phase 3

1 2

Cytalux

OOn Target Laboratories, LLC

Phase 3

1 3

Octreotide

Johnson & Johnson

Preclinical

1 4

Mosapride citrate

IlDong Pharmaceutical Co Ltd

Phase 2

1 5

Buscopan

Boehringer Ingelheim

Preclinical

1 6

Dachengqi Decoction

XXinhua Hospital, Shanghai Jiao Tong University School of Medicine

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Dyspepsia2 trials

Clinical Trial to Assess the Efficacy and Safety of Combination Therapy of Motireb 5/100 mg in Functional Dyspepsia Patients.

Unknown status· IlDong Pharmaceutical Co Ltd logo

IlDong Pharmaceutical Co Ltd·Phase 3·NCT02831543·354 enrolled

Zuojin Wan Combined With Rabeprazole or Mosapride for the Treatment of Functional Dyspepsia Combined With Depression

Not yet recruiting·NNanjing First Hospital, Nanjing Medical University·N/A·NCT06481371·120 enrolled

Constipation2 trials

Efficacy and Safety of Acupuncture for Functional Constipation

Completed·GGuang'anmen Hospital of China Academy of Chinese Medical Sciences·Phase 3·NCT01411501·684 enrolled

Efficacy of Yìqì Jiànpí Decoction Combined With Plant Lactobacillus in Treating Slow Transit Constipation: A Randomized Controlled Trial

Completed·FFirst People's Hospital Of Lin'an District, Hangzhou·Preclinical·NCT07757061·120 enrolled

Gastrointestinal Dysfunction1 trial

A Phase Ⅱ Study of Mosapride Citrate Injection in the Treatment of Postoperative Gastrointestinal Dysfunction

Recruiting·SShandong New Time Pharmaceutical Co., LTD·Phase 2·NCT06782594·150 enrolled

Acupuncture1 trial

Trial for Quantity-Effect Relationship of Acupuncture With Two-ways Regulation to Treat Functional Enteropathy

Unknown status·HHuazhong University of Science and Technology·Phase 1·NCT01274793·240 enrolled

Critically Ill Patients1 trial

A Comparative Evaluation of Mosapride Versus Metoclopramide for Enteral Feeding Intolerance in Critically Ill Patients

Not yet recruiting·—·Phase 3·NCT06826443·100 enrolled

7 more indications

Concentration1 trial

The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones

Completed·SSeoul National University Hospital·Phase 4·NCT02180334·12 enrolled

Irritable Bowel Syndrome1 trial

Randomized Trial of Mosapride Versus Placebo in the Treatment of Constipation-Predominant Irritable Bowel Syndrome

Terminated·—·Phase 3·NCT00742872·41 enrolled

Bowel Preparation1 trial

Free-residue Nutrients for the Bowel Preparation of Colon Capsule Endoscopy

Unknown status·KKaichun Wu·Phase 4·NCT02887573·62 enrolled

Interaction1 trial

A Drug Interaction Study of Mosapride and Rebamipide

Completed· IlDong Pharmaceutical Co Ltd logo

IlDong Pharmaceutical Co Ltd·Phase 1·NCT02106130·40 enrolled

Gastrointestinal1 trial

Effect of Mosapride Citrate on Gastrointestinal Motility After Laparoscopic Gastrectomy

Completed·GGangnam Severance Hospital·N/A·NCT04493125·104 enrolled

Herbal Medicine1 trial

Efficacy Assessment of Chinese Herbal Medicine Tangweian Recipe Treating Participants With Diabetic Gastroenteropathy

Unknown status·GGuang'anmen Hospital of China Academy of Chinese Medical Sciences·Phase 1/2·NCT05720442·60 enrolled

Unspecified1 trial

Clinical Study on Post Evaluation After Listing of Qizhi Weitong Granules

Unknown status·XXiyuan Hospital of China Academy of Chinese Medical Sciences·Phase 1/2·NCT03149393·384 enrolled

Sources

References

[1]
ClinicalTrials.gov — 14 trial records for Mosapride citrate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Mosapride citrate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Mosapride citrate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — IlDong Pharmaceutical Co Ltd company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: IlDong Pharmaceutical Co Ltd

Mosapride citrate

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Dyspepsia2 trials

Constipation2 trials

Gastrointestinal Dysfunction1 trial

Acupuncture1 trial

Critically Ill Patients1 trial

Concentration1 trial

Irritable Bowel Syndrome1 trial

Bowel Preparation1 trial

Interaction1 trial

Gastrointestinal1 trial

Herbal Medicine1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News